Known for its extreme volatility, the digital currency ecosystem is also being weighed down the way most traditional stock market indices are.
Nasdaq’s major challenge in 2021 was the decline across companies that picked up huge market value in 2020.
There are key industries that showcased growth and downtrend as the Omicron concerns stirred a new way of precautions including restrictions amongst governments.
With the restrictions, the entire global market will slip to the downturn experienced in the first quarter and an early second quarter last year when the COVID-19 pandemic was just building its harsh momentum.
A number of economic policies continue to make their way into the stock market, most of which have the potential to induce a targeted rally in key aspects of the market.
The spread of Omicron variant combined with the Fed’s tapering measures have put pressure on stocks leading to major sell-offs over the last week.
The relentless spread of the Omicron variant has adversely impacted European and Asian markets, even oil prices too.
The Bitwise NFT Index fund is arguably the very first of its kind as the company seeks to bolster its presence as a reliable outfit that offers both retail and institutional investors an alternative avenue to partake in the ongoing cryptocurrency revolution.
The stoppage of the Federal Reserve Bond purchase has been cited as a bold move by many analysts who noted the plan provides a good certainty for growth.
The current outlook of the stock market indices is very different from the trend observed in the past week where we saw a bullish rally across the board.
The US stock rallied for the second consecutive day as Wall Street investors shrugged off the fears of the Omicron Covid variant. Tech stocks gained heavily on Tuesday.
FTSE says its crypto index will be on the same rung as its FTSE 100 and Russell 2000, and will feature 43 different crypto assets.
Amid investors’ close monitoring of the ermerging COVID Omicron variant and oil price increase, European stocks were on the rise early on Monday.
While the big cap stocks are feeling the weight of reality in the broader stock market, the Russell 2000, a benchmark for small-cap stocks, also fell 3.86% in a week.
While pharmaceutical outfits will be looking at modifying existing COVID-19 vaccine formulas to combat Omicron, the ensuing lockdown is an indication that the world is bound to have a long ride with this new coronavirus variant.